These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5352752)

  • 1. Rabbit C3 isolation and characterization of reactions in vitro and during in vivo antigen-antibody interaction.
    Propp RP; Alper CA
    Immunology; 1969 Nov; 17(5):695-707. PubMed ID: 5352752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The isolation of soluble antigen-antibody complexes on Sephadex G-200.
    Boyns AR; Hardwicke J
    Immunology; 1966 Jan; 10(1):57-61. PubMed ID: 5930879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between complement, the heterogeneity of antibody and anaphylaxis.
    Pondman KW; van Es L; Schuurs A
    Bibl Haematol; 1965; 23():825-8. PubMed ID: 4160211
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and characterization of a trypsin-cleaved fragment derived from the third component of guinea pig complement bound to zymosan.
    Takahashi M; Takahashi S; Motonishi K
    Jpn J Exp Med; 1974 Dec; 44(6):547-51. PubMed ID: 4477225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antigen-antibody reactions in the gastric mucosa. Passive mucosal anaphylaxis and application of soluble antigen-antibody complex for the mucosa].
    Kondo M; Yamashita S; Chikamatsu S; Sasaki T; Wakabayashi T
    Arerugi; 1966 Jun; 15(6):415-21. PubMed ID: 4164261
    [No Abstract]   [Full Text] [Related]  

  • 7. Univalent antigen as elicitor of anaphylactic reactions.
    Green JF; Thielke KG; Raffel S
    J Immunol; 1970 Apr; 104(4):863-73. PubMed ID: 5442840
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological studies on the adverse effects of dextran].
    Richter W
    Klin Anasthesiol Intensivther; 1975; 9():48-57. PubMed ID: 1234607
    [No Abstract]   [Full Text] [Related]  

  • 9. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological induction of increased vascular permeability. II. Two mechanisms of histamine release from rabbit platelets involving complement.
    Henson PM; Cochrane CG
    J Exp Med; 1969 Jan; 129(1):167-84. PubMed ID: 4178112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of bound C3 by a new immunochemical methods.
    Borsos T; Leonard EJ
    J Immunol; 1971 Sep; 107(3):766-71. PubMed ID: 5315244
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitor of human C3 associated with preparations of C3 dissociated from C3-zymosan complex.
    Blum L
    J Immunol; 1969 Nov; 103(5):1116-24. PubMed ID: 5350971
    [No Abstract]   [Full Text] [Related]  

  • 13. A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.
    Assimeh SN; Bing DH; Painter RH
    J Immunol; 1974 Jul; 113(1):225-34. PubMed ID: 4857625
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and identification of the third component of complement of Japanese quails.
    Kai C; Yoshikawa Y; Yamanouchi K; Okada H
    J Immunol; 1983 Jun; 130(6):2814-20. PubMed ID: 6343485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 16. Site of deposition of C3 in Arthus reactions of C4 deficient guinea pigs.
    Frank MM; Green EI; Cochrane CG
    J Immunol; 1973 May; 110(5):1447-51. PubMed ID: 4266836
    [No Abstract]   [Full Text] [Related]  

  • 17. Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum.
    König W; Bitter-Suermann D; Dierich M; Hadding U
    Immunochemistry; 1973 Jul; 10(7):431-7. PubMed ID: 4125109
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic aspects of diseases of complement: an explosion.
    Polley MJ; Bearn AG
    Am J Med; 1975 Jan; 58(1):105-11. PubMed ID: 46701
    [No Abstract]   [Full Text] [Related]  

  • 19. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 20. The purification and reactivity of the first component of complement from guinea pig, human and canine sera.
    Tamura N; Nelson RA
    J Immunol; 1968 Dec; 101(6):1333-45. PubMed ID: 4972623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.